aClinical Science, Universidad de Monterrey, Monterrey, Mexico
bBliss Medical, Monterrey, Mexico
cMARSU Dermatología, Puebla, Mexico
dDepartment of Dermatology, University of Miami, Miami, FL, USA
Log in to MyKarger to check if you already have access to this content.
Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price. Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more Select* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication DetailsFirst-Page Preview
Received: July 12, 2022
Accepted: September 18, 2022
Published online: November 01, 2022
Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 2
ISSN: 2296-9195 (Print)
eISSN: 2296-9160 (Online)
For additional information: https://www.karger.com/SAD
AbstractBackground: The Women’s Androgenetic Alopecia Quality of Life (WAA-QoL) questionnaire is the only available specific instrument to evaluate QoL in female pattern hair loss (FPHL) patients. It is made of 16 questions with 6 alternatives, is self-administered, and has not yet been adapted or validated to Spanish. Objectives: The objective of the study was to translate into Spanish, culturally adapt, and validate the WAA-QoL questionnaire. Methods: The translated version (WAA-QoL-sp) was submitted to 453 general population women by e-mail after authorization by the author, translation, and adaptation to Spanish of the WAA-QoL questionnaire. Results: A total of 453 women were evaluated; the median age was 39 years, and there was high internal consistency: Cronbach’s alpha was 0.969 for the WAA-QoL-sp. Study Limitations: Sampling of subjects was from diverse Spanish-speaking countries (such as Mexico, Colombia, Chile, Venezuela, Cuba, and Spain) but not from all Spanish-speaking countries. Conclusions: A Spanish version of the WAA-QoL questionnaire was translated and adapted, which proved to be consistent and a valid tool for assessment of FPHL.
© 2022 S. Karger AG, Basel
References Camacho-Martínez FM. Hair loss in women. Semin Cutan Med Surg. 2009 Mar;28(1):19–32. Tosti A, Piraccini BM, Sisti A, Duque-Estrada B. Hair loss in women. Minerva Ginecol. 2009 Oct;61(5):445–52. Zhuang XS, Zheng YY, Xu JJ, Fan WX. Quality of life in women with female pattern hair loss and the impact of topical minoxidil treatment on quality of life in these patients. Exp Ther Med. 2013;6(2):542–6. Starace M, Orlando G, Alessandrini A, Piraccini BM. Female androgenetic alopecia: an update on diagnosis and management. Am J Clin Dermatol. 2020 Feb;21(1):69–84. Girman CJ, Hartmaier S, Roberts J, Bergfeld W, Waldstreicher J. Patient-perceived importance of negative effects of androgenetic alopecia in women. J Womens Health Gend Based Med. 1999 Oct;8(8):1091–5. Biondo S, Sinclair R. Quality of life in Australian women with female pattern hair loss. Open Dermatol J. 2010;4:90–4. Schmidt S, Fischer TW, Chren MM, Strauss BM, Elsner P. Strategies of coping and quality of life in women with alopecia. Br J Dermatol. 2001;144(5):1038–43. Dolte KS, Girman CJ, Hartmaier S, Roberts J, Bergfeld W, Waldstreicher J. Development of a health-related quality of life questionnaire for women with androgenetic alopecia. Clin Exp Dermatol. 2000;25(8):637–42. IBM Corp. IBM SPSS 22.0 statistics for windows. Armonk, NY: IBM Corp; 2013. Shimizu GKM, Wedy GF, Schaefer LV, Ramos PM, Miot HA. Translation into Portuguese language (Brazil), transcultural adaptation and validation of the quality of life questionnaire in female pattern hair loss (WAA-QoL-BP). An Bras Dermatol. 2018 Sep–Oct;93(5):701–6. Article / Publication DetailsFirst-Page Preview
Received: July 12, 2022
Accepted: September 18, 2022
Published online: November 01, 2022
Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 2
ISSN: 2296-9195 (Print)
eISSN: 2296-9160 (Online)
For additional information: https://www.karger.com/SAD
Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
留言 (0)